2025年全球先進藥物輸送系統市場報告

近年來，先進藥物輸送系統市場規模強勁成長，從2024年的2,699.9億美元增加至2025年的2,855.9億美元，複合年成長率為5.8%。這段歷史時期的成長可歸因於患者依從性的提高、藥品專利到期、個人化醫療、慢性病流行的增加、生技藥品和大分子藥物。

預計未來幾年先進藥物輸送系統市場規模將強勁成長，到2029年將達到3,982.4億美元，複合年成長率為8.7%。預測期內的成長可歸因於患者友好的給藥途徑、對罕見疾病的關注、數位健康整合、以患者為中心的藥物開發、遠端保健的影響、基因治療和RNA療法、基於外泌體的藥物輸送以及遠端監控設備。預測期內的主要趨勢包括奈米技術的進步、智慧藥物傳輸系統、藥物製劑中的3D列印、人工智慧的整合以及永續的藥物傳輸。

先進藥物輸送系統 (ADDS) 是指旨在增強藥物靶向分佈、生物有效性和療效的創新技術和配方。這些系統旨在最大限度地提高藥物療效，同時最大限度地減少副作用，控制藥物釋放速率，並靶向作用於體內特定部位。

先進的藥物遞送系統的主要類型包括口服藥物遞送系統、注射藥物遞送系統、吸入或肺部藥物遞送系統、經皮藥物遞送系統、粘膜藥物遞送系統和基於載體的藥物遞送系統。口服藥物遞送系統透過口腔或消化道引入化學物質進行全身性遞送。這些系統中使用的載體類型包括脂質體、奈米顆粒、微球和單株抗體。所採用的各種技術包括前驅藥物、植入、子宮內避孕器、標靶藥物遞送和大分子藥物遞送。這些遞送系統應用於心血管疾病、腫瘤學、泌尿學、糖尿病、中樞神經系統 (泌尿系統) 疾病、眼科、發炎性疾病和感染疾病等適應症。它們被用於醫院、專科診所和臨床研發中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

先進藥物輸送系統研究報告是商業研究公司最新報告系列的一部分，該系列提供先進藥物輸送系統市場統計數據，例如全球市場規模、區域佔有率、先進藥物輸送系統市場佔有率的競爭對手、先進的藥物輸送系統細分市場、市場趨勢以及先進藥物輸送系統行業的商機。這份先進的藥物輸送系統市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年8.7%的預測成長率，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。美國可能會直接感受到這種影響，因為韓國的微針陣列貼片和瑞士的可生物分解聚合物基質供不應求，這可能會推遲新的給藥方法的推出。此外，這種影響還可能透過互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，在更廣泛的範圍內產生影響。

預計慢性病的預期成長將推動先進藥物輸送系統市場的成長。持續一年以上且需要持續醫療照護的慢性病是由各種風險行為引起的，例如吸菸、接觸二手菸、營養不良、缺乏運動和過量飲酒。先進的藥物輸送系統在將治療藥物精確輸送到受慢性病影響的特定部位、提高療效和最大限度地減少副作用方面發揮關鍵作用。例如，根據聯合國 (UN) 截至 2023 年 5 月的數據，慢性病占美國死亡人數的十分之七，每年導致超過 170 萬人死亡。因此，慢性病盛行率的上升正在支持先進藥物輸送系統市場的成長。

個人化醫療趨勢預計將推動先進藥物輸送系統市場的發展。個人化醫療，也稱為精準醫療，將基因、環境和生活方式等個別差異納入考量，以實現客製化醫療。先進的藥物傳遞系統有助於將藥物精準輸送至患病細胞和組織，減少藥物對健康器官的暴露，並最大限度地降低副作用。根據個人化醫療聯盟2023年2月的數據，個人化醫療占美國食品藥物管理局（FDA）2022年核准新藥的34%，較前八年顯著成長。因此，個人化醫療的日益成長趨勢正在推動先進藥物輸送系統市場的發展。

技術進步是先進藥物輸送系統市場的一個顯著趨勢，主要企業紛紛採用新技術以維持其市場地位。 2023年6月，總部位於印度的原料藥及製劑製造商和供應商Shilpa Medicare Limited推出了全球首款兒科乙醯胺酚口服薄膜製劑Molshil。這款創新的對乙醯胺酚製劑具有良好的偏好和易於服用的特點，消除了兒科製劑的許多缺點。

先進藥物輸送系統市場的主要企業正優先考慮以本土藥物輸送系統為重點的策略夥伴關係關係，以提高療效和可及性。這些合作夥伴關係強調創新和簡化的開發流程。本土藥物傳遞系統可以利用本地資源和傳統知識有效地進行治療，並優先考慮生物相容性和文化相關性，從而改善特定人群的健康狀況。例如，2022年6月，印度製藥公司Gufiq Biosciences推出了雙室袋（DCB）。該系統透過無菌、易於使用的設計確保安全性和穩定性，從而增強藥物輸送，降低污染和給藥錯誤的風險。它也促進了本土生產，使醫療保健更加經濟實惠，同時提高了重組藥物的療效。

2022年5月，美國生物製藥公司Halozyme Therapeutics收購了美國特種製藥公司Antares Pharma。 Halozyme旨在透過此次收購鞏固其作為領先藥物輸送公司的地位，並憑藉其一流的自動注射器技術和專業的商業業務，拓展其產品線，覆蓋特種產品。

先進藥物輸送系統市場的主要參與者包括輝瑞公司、強生服務公司、羅氏控股、艾伯維、拜耳、諾華、Astra Zeneca實驗室、GlaxoSmithKline Plc、3M、Medtronic、禮來公司、勃林格殷格翰、安進、默克公司、碧迪公司、默克集團、碧迪公司、百特國際公司、梯瓦製藥工業有限公司、賽諾菲公司、波士頓科學公司、邁蘭公司、Astellas製藥公司、康泰倫特公司、尼普洛公司、阿普塔集團公司、West Pharmaceutical Services公司、格雷斯海姆股份公司及Inslet公司。

2024年先進藥物輸送系統市場最大的地區是北美。預計亞太地區將成為預測期內成長最快的地區。先進藥物輸送系統市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。

先進藥物輸送系統市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、義大利、西班牙和加拿大。

先進藥物傳輸系統市場由提供刺激響應型藥物傳輸系統、持續性藥物傳輸系統、靶向性藥物傳輸系統和奈米顆粒藥物傳輸系統的營業單位所獲得的收益所構成。市場價值包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。先進藥物傳輸系統市場還包括Fentanyl經皮貼片、沙丁胺醇吸入器和水凝膠的銷售。此市場的價值代表“出廠價”，即產品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的產品價值。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球先進藥物輸送系統：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球先進藥物輸送系統市場：成長率分析
• 全球先進藥物傳輸系統市場表現：規模與成長，2019-2024
• 全球先進藥物傳輸系統市場預測：規模與成長，2024-2029年，2034年
• 全球先進藥物輸送系統：總目標市場（TAM）

第6章 市場細分

• 全球先進藥物輸送系統市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 口服給藥系統
• 注射藥物輸送系統
• 吸入或肺部給藥系統
• 經皮給藥系統
• 粘膜給藥系統
• 基於載體的藥物傳輸系統
• 其他類型
• 全球先進藥物輸送系統市場（按載體類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 脂質體
• 奈米粒子
• 微球
• 單株抗體
• 其他承運商類型
• 全球先進藥物輸送系統市場：按技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 前驅藥物
• 植入和子宮內避孕器
• 靶向藥物輸送
• 聚合物藥物輸送
• 其他技術
• 全球先進藥物傳輸系統市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 心血管疾病
• 腫瘤學
• 泌尿系統
• 糖尿病
• 中樞神經系統（CNS）
• 眼科
• 發炎性疾病
• 感染疾病
• 其他用途
• 全球先進藥物輸送系統市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 專科診所
• 臨床研究與開發中心
• 全球先進藥物輸送系統市場：口服藥物輸送系統細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 固態劑型
• 液體劑型
• 新型口服給藥系統
• 全球先進藥物輸送系統市場：細分：注射式藥物輸送系統（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 傳統注射系統（注射器、管瓶）
• 預填充式注射器
• 自動注射器
• 基於微針的系統
• 全球先進藥物輸送系統市場：依吸入或肺部藥物輸送系統細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 定量噴霧吸入器（MDI）
• 乾粉吸入器（DPI）
• 噴霧器
• 緩霧吸入器
• 全球先進藥物輸送系統市場：經皮藥物輸送系統細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 經皮吸收貼片
• 微針貼片
• 離子電滲系統
• 全球先進藥物輸送系統市場：經粘膜藥物輸送系統細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 頰側給藥系統
• 舌下給藥系統
• 鼻腔給藥系統
• 直腸輸送系統
• 全球先進藥物輸送系統市場：基於載體的藥物輸送系統細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 脂質體
• 奈米粒子
• 樹狀聚合物
• 囊泡
• 全球先進藥物輸送系統市場：按類型、實際和預測細分，2019-2024 年、2024-2029 年、2034 年
• 植入式藥物傳輸系統
• 標靶遞送系統
• 生物黏附藥物傳輸系統

第7章 區域和國家分析

• 全球先進藥物輸送系統市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
• 全球先進藥物輸送系統市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 先進藥物輸送系統市場：競爭格局
• 先進藥物輸送系統市場：公司簡介
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Novartis AG
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• 3M Company
• Medtronic plc
• Eli Lilly and Company
• Boehringer Ingelheim GmbH
• Amgen Inc.
• Merck Group
• Becton Dickinson and Company
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Sanofi SA
• Boston Scientific Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年先進藥物輸送系統市場：提供新機會的國家
• 2029年先進藥物輸送系統市場：細分市場帶來新機會
• 2029年先進藥物輸送系統市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Advanced drug delivery systems refer to innovative techniques and formulations designed to enhance the targeted distribution, bioavailability, and efficacy of pharmaceutical medications. These systems aim to maximize drug efficacy while minimizing side effects, providing controlled drug release rates, and targeting specific areas of the body.

The main types of advanced drug delivery systems include oral drug delivery systems, injection-based drug delivery systems, inhalation or pulmonary drug delivery systems, transdermal drug delivery systems, transmucosal drug delivery systems, carrier-based drug delivery systems, and others. The oral drug delivery system involves introducing a chemical through the mouth or into the gastrointestinal tract for systemic activity. Carrier types in these systems include liposomes, nanoparticles, microspheres, monoclonal antibodies, and others. Various technologies, such as prodrugs, implants, intrauterine devices, targeted drug delivery, polymeric drug delivery, and others, are employed. These delivery systems find applications in indications such as cardiovascular diseases, oncology, urology, diabetes, central nervous system (CNS) disorders, ophthalmology, inflammatory diseases, infections, and more. They are utilized by hospitals, specialized clinics, and clinical research and development centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The advanced drug delivery systems research report is one of a series of new reports from The Business Research Company that provides advanced drug delivery systems market statistics, including the advanced drug delivery systems industry's global market size, regional shares, competitors with advanced drug delivery systems market share, detailed advanced drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the advanced drug delivery systems industry. This advanced drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The advanced drug delivery systems market size has grown strongly in recent years. It will grow from $269.99 billion in 2024 to $285.59 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to improved patient compliance, drug patent expirations, personalized medicine, chronic disease prevalence, biologics and large molecule drugs.

The advanced drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $398.24 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to patient-friendly routes of administration, focus on rare diseases, digital health integration, patient-centric drug development, telehealth influence, gene therapy and rna therapeutics, exosome-based drug delivery, remote monitoring devices. Major trends in the forecast period include nanotechnology advancements, smart drug delivery systems, 3d printing in drug formulations, integration of artificial intelligence, sustainable drug delivery.

The forecast of 8.7% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through shortages of micro-needle array patches from South Korea and biodegradable polymer matrices from Switzerland, potentially delaying novel medication administration methods.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in chronic conditions is poised to drive the expansion of the advanced drug delivery systems market. Chronic conditions, persisting for a year or longer and necessitating ongoing medical care, are attributed to various risk behaviors such as tobacco use, exposure to secondhand smoke, poor nutrition, physical inactivity, and excessive alcohol use. Advanced drug delivery systems play a crucial role in precisely delivering therapeutic agents to specific sites affected by chronic conditions, enhancing drug effectiveness, and minimizing side effects. For example, as per May 2023 data from The United Nations (UN), chronic diseases account for seven out of 10 deaths in the US, causing over 1.7 million fatalities annually. Consequently, the increasing prevalence of chronic conditions underpins the growth of the advanced drug delivery systems market.

The shifting trend towards personalized medicine is anticipated to fuel the advancement of the advanced drug delivery systems market. Personalized medicine, also known as precision medicine, considers individual differences in genes, environments, and lifestyles for tailored medical care. Advanced drug delivery systems are instrumental in directing drugs precisely to diseased cells or tissues, reducing exposure to healthy organs and minimizing side effects. In February 2023, according to the Personalized Medicine Coalition, personalized drugs constituted 34% of new pharmaceuticals approved by the US Food and Drug Administration in 2022, marking a significant increase from the previous eight years. Therefore, the growing inclination towards personalized medicine is a driving force for the advanced drug delivery systems market.

Technological advancements represent a prominent trend in the advanced drug delivery systems market, with major companies embracing new technologies to maintain their market positions. In June 2023, Shilpa Medicare Limited, an India-based manufacturer and supplier of API and formulations, introduced Molshil, the world's first oral thin film formulation of a pediatric dose of paracetamol. This innovative paracetamol formulation boasts high palatability, ease of administration, and eliminates some disadvantages associated with pediatric formulations.

Major companies in the advanced drug delivery systems market are prioritizing strategic partnerships, such as those focused on indigenous drug delivery systems, to enhance efficacy and accessibility. These collaborations emphasize innovation and streamlined development processes. An indigenous drug delivery system leverages local resources and traditional knowledge to effectively administer therapeutic agents, prioritizing biocompatibility and cultural relevance, which can improve health outcomes in specific populations. For example, in June 2022, Gufic Biosciences, an India-based pharmaceutical company, introduced a Dual Chamber Bag (DCB). This system enhances drug delivery by ensuring safety and stability through a sterile, user-friendly design that reduces the risk of contamination and dosing errors. It also promotes indigenous production, making healthcare more affordable while improving the efficacy of reconstituted medications.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc., a US-based specialty pharmaceutical firm. Through this acquisition, Halozyme aims to strengthen its position as a top drug delivery firm, expanding its approach to covering specialized goods with its best-in-class auto-injector technology and specialty commercial business.

Major companies operating in the advanced drug delivery systems market include Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, Abbvie Inc., Bayer AG, Novartis AG, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, 3M Company, Medtronic plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Amgen Inc., Merck Group, Becton Dickinson and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Boston Scientific Corporation, Mylan N.V., Astellas Pharma Inc., Catalent Inc., Nipro Corporation, AptarGroup Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation

North America was the largest region in the advanced drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the advanced drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The advanced drug delivery systems market consists of revenues earned by entities by providing stimuli-responsive drug delivery systems, sustained drug delivery systems, targeted drug delivery systems, and nanoparticle-based drug delivery systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced drug delivery systems market also consists of sales of fentanyl transdermal patches, albuterol inhalers, and hydrogels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Advanced Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on advanced drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for advanced drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The advanced drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation Or Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System; Other Types
• 2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Monoclonal Antibodies; Other Carrier Types
• 3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies
• 4) By Application: Cardiovascular Diseases; Oncology; Urology; Diabetes; CNS (Central Nervous System); Ophthalmology; Inflammatory Diseases; Infections; Other Applications
• 5) By End User: Hospitals; Specialized clinics; Clinical Research And Development Centers
• Subsegments:
• 1) By Oral Drug Delivery System: Solid Dosage Forms; Liquid Dosage Forms; Novel Oral Delivery Systems
• 2) By Injection-Based Drug Delivery System: Conventional Injection Systems (Syringes, Vials); Prefilled Syringes; Autoinjectors; Microneedle-Based Systems
• 3) By Inhalation Or Pulmonary Drug Delivery System: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers; Soft Mist Inhalers
• 4) By Transdermal Drug Delivery System: Transdermal Patches; Microneedle Patches; Iontophoresis Systems
• 5) By Transmucosal Drug Delivery System: Buccal Delivery Systems; Sublingual Delivery Systems; Nasal Delivery Systems; Rectal Delivery Systems
• 6) By Carrier-Based Drug Delivery System: Liposomes; Nanoparticles; Dendrimers; Niosomes
• 7) By Other Types: Implantable Drug Delivery Systems; Targeted Delivery Systems; Bioadhesive Drug Delivery Systems
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc.; Roche Holding AG; Abbvie Inc.; Bayer AG; Novartis AG; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc; 3M Company; Medtronic plc; Eli Lilly and Company; Boehringer Ingelheim GmbH; Amgen Inc.; Merck Group; Becton Dickinson and Company; Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Sanofi S.A.; Boston Scientific Corporation; Mylan N.V.; Astellas Pharma Inc.; Catalent Inc.; Nipro Corporation; AptarGroup Inc.; West Pharmaceutical Services Inc.; Gerresheimer AG; Insulet Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Advanced Drug Delivery Systems Market Characteristics

3. Advanced Drug Delivery Systems Market Trends And Strategies

4. Advanced Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Advanced Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Advanced Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Advanced Drug Delivery Systems Market Growth Rate Analysis
• 5.4. Global Advanced Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Advanced Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Advanced Drug Delivery Systems Total Addressable Market (TAM)

6. Advanced Drug Delivery Systems Market Segmentation

• 6.1. Global Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Drug Delivery System
• Injection-Based Drug Delivery System
• Inhalation Or Pulmonary Drug Delivery System
• Transdermal Drug Delivery System
• Transmucosal Drug Delivery System
• Carrier-Based Drug Delivery System
• Other Types
• 6.2. Global Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liposomes
• Nanoparticles
• Microspheres
• Monoclonal Antibodies
• Other Carrier Types
• 6.3. Global Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prodrug
• Implants And Intrauterine Devices
• Targeted Drug Delivery
• Polymeric Drug Delivery
• Other Technologies
• 6.4. Global Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Oncology
• Urology
• Diabetes
• CNS (Central Nervous System)
• Ophthalmology
• Inflammatory Diseases
• Infections
• Other Applications
• 6.5. Global Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialized clinics
• Clinical Research And Development Centers
• 6.6. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Oral Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Dosage Forms
• Liquid Dosage Forms
• Novel Oral Delivery Systems
• 6.7. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Injection-Based Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Injection Systems (Syringes, Vials)
• Prefilled Syringes
• Autoinjectors
• Microneedle-Based Systems
• 6.8. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Inhalation Or Pulmonary Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered-Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs)
• Nebulizers
• Soft Mist Inhalers
• 6.9. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Transdermal Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transdermal Patches
• Microneedle Patches
• Iontophoresis Systems
• 6.10. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Transmucosal Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal Delivery Systems
• Sublingual Delivery Systems
• Nasal Delivery Systems
• Rectal Delivery Systems
• 6.11. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Carrier-Based Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liposomes
• Nanoparticles
• Dendrimers
• Niosomes
• 6.12. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implantable Drug Delivery Systems
• Targeted Delivery Systems
• Bioadhesive Drug Delivery Systems

7. Advanced Drug Delivery Systems Market Regional And Country Analysis

• 7.1. Global Advanced Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Advanced Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Advanced Drug Delivery Systems Market

• 8.1. Asia-Pacific Advanced Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Advanced Drug Delivery Systems Market

• 9.1. China Advanced Drug Delivery Systems Market Overview
• 9.2. China Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Advanced Drug Delivery Systems Market

• 10.1. India Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Advanced Drug Delivery Systems Market

• 11.1. Japan Advanced Drug Delivery Systems Market Overview
• 11.2. Japan Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Advanced Drug Delivery Systems Market

• 12.1. Australia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Advanced Drug Delivery Systems Market

• 13.1. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Advanced Drug Delivery Systems Market

• 14.1. South Korea Advanced Drug Delivery Systems Market Overview
• 14.2. South Korea Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Advanced Drug Delivery Systems Market

• 15.1. Western Europe Advanced Drug Delivery Systems Market Overview
• 15.2. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Advanced Drug Delivery Systems Market

• 16.1. UK Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Advanced Drug Delivery Systems Market

• 17.1. Germany Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Advanced Drug Delivery Systems Market

• 18.1. France Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Advanced Drug Delivery Systems Market

• 19.1. Italy Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Advanced Drug Delivery Systems Market

• 20.1. Spain Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Advanced Drug Delivery Systems Market

• 21.1. Eastern Europe Advanced Drug Delivery Systems Market Overview
• 21.2. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Advanced Drug Delivery Systems Market

• 22.1. Russia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Advanced Drug Delivery Systems Market

• 23.1. North America Advanced Drug Delivery Systems Market Overview
• 23.2. North America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Advanced Drug Delivery Systems Market

• 24.1. USA Advanced Drug Delivery Systems Market Overview
• 24.2. USA Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Advanced Drug Delivery Systems Market

• 25.1. Canada Advanced Drug Delivery Systems Market Overview
• 25.2. Canada Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Advanced Drug Delivery Systems Market

• 26.1. South America Advanced Drug Delivery Systems Market Overview
• 26.2. South America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Advanced Drug Delivery Systems Market

• 27.1. Brazil Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Advanced Drug Delivery Systems Market

• 28.1. Middle East Advanced Drug Delivery Systems Market Overview
• 28.2. Middle East Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Advanced Drug Delivery Systems Market

• 29.1. Africa Advanced Drug Delivery Systems Market Overview
• 29.2. Africa Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Advanced Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 30.1. Advanced Drug Delivery Systems Market Competitive Landscape
• 30.2. Advanced Drug Delivery Systems Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Advanced Drug Delivery Systems Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. AstraZeneca plc
• 31.3. Abbott Laboratories
• 31.4. GlaxoSmithKline plc
• 31.5. 3M Company
• 31.6. Medtronic plc
• 31.7. Eli Lilly and Company
• 31.8. Boehringer Ingelheim GmbH
• 31.9. Amgen Inc.
• 31.10. Merck Group
• 31.11. Becton Dickinson and Company
• 31.12. Baxter International Inc.
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Sanofi S.A.
• 31.15. Boston Scientific Corporation

32. Global Advanced Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Advanced Drug Delivery Systems Market

34. Recent Developments In The Advanced Drug Delivery Systems Market

35. Advanced Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 35.1 Advanced Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Advanced Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Advanced Drug Delivery Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer